Tensha Therapeutics develops small molecule bromodomain inhibitors to treat cancer and other serious disorders. read more
Tensha Therapeutics CEO & Leadership Team Ratings
Douglas Onsi and the Tensha Therapeutics leadership team are scored a C- by 3 employees placing it in the Bottom 35% of companies sized 10,000+ Employees on Comparably. The Leadership score includes details about how employees evaluate their executive team, CEO and manager.
Based on 24 ratings, the Leadership score of 63/100 combines employee feedback on their CEO (53/100), Manager (29/100), and Executive Team (85/100).
Douglas Onsi Tensha Therapeutics CEO Rating
Bottom 10% Compared to other companies of similar size in BostonD-
53 / 100
Douglas Onsi the CEO of Tensha Therapeutics received an average score of 53 from Tensha Therapeutics employees.Tensha Therapeutics Manager Rating
Bottom 5% Compared to other companies of similar size in BostonF
29 / 100
Tensha Therapeutics Executive Team Rating
Top 5% Compared to other companies of similar size in BostonA+
85 / 100
×